We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
Cap. Flow
-$4.28B
Cap. Flow %
-30.25%
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98

Top Buys

Rank Stock Value
1
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
+$61M
2
RTX icon
RTX Corp
RTX
+$38.2M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$15.5M
4
DAL icon
Delta Air Lines
DAL
+$14.5M
5
SWT
Stanley Black & Decker, Inc.
SWT
+$13.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$578M
2
AGN
Allergan plc
AGN
+$67M
3
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
+$51.1M
4
BABA icon
Alibaba
BABA
+$46.8M
5
LULU icon
lululemon athletica
LULU
+$42M

Sector Composition

Rank Sector Weight
1 Technology 14.91%
2 Healthcare 8.15%
3 Consumer Discretionary 7.49%
4 Financials 7.2%
5 Communication Services 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTN
626
DELISTED
Raytheon Company
RTN
– –
-250,709
Closed -$32.9M
RARX
627
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-122,600
Closed -$5.89M
TLRA
628
DELISTED
Telaria, Inc.
TLRA
– –
-364,526
Closed -$2.19M
CY
629
DELISTED
Cypress Semiconductor
CY
– –
-195,944
Closed -$4.57M
22 23 24 25
26

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Calamos Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.

  • Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
  • Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
  • Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
  • Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
  • Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
  • Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
  • Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.

Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.